Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The selective oestrogen receptor modulation: evolution and clinical applications.

× No keyword cloud information.

36 in total

1. Induction of ovulation.

Authors: R B GREENBLATT; S ROY; V B MAHESH; W E BARFIELD; E C JUNGCK
Journal: Am J Obstet Gynecol Date: 1962-10-01 Impact factor: 8.661

2. A non-steroidal estrogen antiagonist 1-(p-2-diethylaminoethoxyphenyl)-1-phenyl-2-p-methoxyphenyl ethanol.

Authors: L J LERNER; F J HOLTHAUS; C R THOMPSON
Journal: Endocrinology Date: 1958-09 Impact factor: 4.736

3. Effects of anti-estrogens on bone in castrated and intact female rats.

Authors: V C Jordan; E Phelps; J U Lindgren
Journal: Breast Cancer Res Treat Date: 1987-10 Impact factor: 4.872

4. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer.

Authors:
Journal: Lancet Date: 1997-10-11 Impact factor: 79.321

5. The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation.

Authors: S R Cummings; S Eckert; K A Krueger; D Grady; T J Powles; J A Cauley; L Norton; T Nickelsen; N H Bjarnason; M Morrow; M E Lippman; D Black; J E Glusman; A Costa; V C Jordan
Journal: JAMA Date: 1999-06-16 Impact factor: 56.272

6. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators.

Authors: B Ettinger; D M Black; B H Mitlak; R K Knickerbocker; T Nickelsen; H K Genant; C Christiansen; P D Delmas; J R Zanchetta; J Stakkestad; C C Glüer; K Krueger; F J Cohen; S Eckert; K E Ensrud; L V Avioli; P Lips; S R Cummings
Journal: JAMA Date: 1999-08-18 Impact factor: 56.272

7. Clomiphene protects against osteoporosis in the mature ovariectomized rat.

Authors: P T Beall; L K Misra; R L Young; H J Spjut; H J Evans; A LeBlanc
Journal: Calcif Tissue Int Date: 1984-01 Impact factor: 4.333

8. Effect of steroidal and nonsteroidal antiestrogens on the growth of a tamoxifen-stimulated human endometrial carcinoma (EnCa101) in athymic mice.

Authors: M M Gottardis; M E Ricchio; P G Satyaswaroop; V C Jordan
Journal: Cancer Res Date: 1990-06-01 Impact factor: 12.701

9. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study.

Authors: M J Stampfer; G A Colditz; W C Willett; J E Manson; B Rosner; F E Speizer; C H Hennekens
Journal: N Engl J Med Date: 1991-09-12 Impact factor: 91.245

10. On the Treatment of Inoperable Cases of Carcinoma of the Mamma: Suggestions for a New Method of Treatment, with Illustrative Cases.

Authors: George T Beatson
Journal: Trans Med Chir Soc Edinb Date: 1896

3 in total

1. Effects of tamoxifen on myocardial ischemia-reperfusion injury model in ovariectomized rats.

Authors: Rauf Onur Ek; Yuksel Yildiz; Serpil Cecen; Cigdem Yenisey; Tulay Kavak
Journal: Mol Cell Biochem Date: 2007-11-03 Impact factor: 3.396

2. Antiandrogens act as selective androgen receptor modulators at the proteome level in prostate cancer cells.

Authors: Greg N Brooke; Simon C Gamble; Michael A Hough; Shajna Begum; D Alwyn Dart; Michael Odontiadis; Sue M Powell; Flavia M Fioretti; Rosie A Bryan; Jonathan Waxman; Robin Wait; Charlotte L Bevan
Journal: Mol Cell Proteomics Date: 2015-02-18 Impact factor: 5.911

3. The Effect of Selective Estrogen Receptor Modulators (SERMs) on the Tamoxifen Resistant Breast Cancer Cells.

Authors: Bo Yoon Chang; Sae Am Kim; Bindu Malla; Sung Yeon Kim
Journal: Toxicol Res Date: 2011-06

3 in total